According to UP researchers that led the clinical studies of lagundi as adjunct treatment for mild COVID-19 symptoms on patients without comorbidities, taking the prescribed dosages will ease the symptoms.
Dr. Jomar Rabajante, the UP Pandemic Response Team’s modeling and analytics lead, shared that we may see a peak of 20,000 to 40,000 active cases between mid-January to the third week of February.
To help protect children with comorbidities against COVID-19, the Philippine General Hospital will be joining other government hospitals in administering vaccines that have secured Emergency Use Authorization from the Food and Drug Administration to children ages 12-17.
The Philippine Genome Center will focus its efforts in the detection of COVID-19 variants in the country, with the scaling down of its testing operations for COVID-19 and expansion of genomic sequencing capacities in PGC Visayas and PGC Mindanao.
UP health experts weigh in on how vaccine hesitancy contributes to the mutation and formation of variants of the SARS-CoV-2 virus.